Swedencare AB (SWDCF) Stock Price & Analysis
SWDCF Stock Chart & Stats
- Day’s Range
- $2.22 - $2.52
- 52-Week Range
- $1.90 - $4.55
- Previous Close
- $2.37
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $309.07M
- Enterprise Value
- $5.10B
- Total Cash (Recent Filing)
- $91.20M
- Total Debt (Recent Filing)
- $1.69B
- Price to Earnings (P/E)
- 35.2
- Beta
- -0.00
- Next Earnings
- Feb 11, 2027 (Est.)
- EPS Estimate
- 0.03
- Last Dividend Ex-Date
- Apr 27, 2026
- Dividend Yield
- 1.28%
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
The strong TTM revenue increase, together with multi-year expansion, indicates continued market demand for Swedencare’s products. Sustained top-line growth can broaden distribution, increase brand reach, and provide a larger base from which operating efficiency and future earnings can develop.
Manageable Leverage
Moderate leverage and a sizeable equity base provide financial resilience and preserve flexibility for ongoing operations, product investment, and expansion. The improvement from 2025 also reduces balance-sheet pressure, making the company better positioned to absorb operating volatility.
Diversified Branded Product Model
Selling branded, consumable pet-health products through veterinary, retail, and online channels diversifies customer access and reduces reliance on one route to market. Repeat purchases tied to ongoing pet care can support recurring demand, while international distribution broadens growth opportunities.
Bears Say
Margin Compression
The substantial decline in gross margin and low net margin show that revenue growth is not translating efficiently into bottom-line earnings. If the pressure persists, weaker profitability could constrain reinvestment, reduce earnings resilience, and make future growth more dependent on continued sales expansion.
Weakening Cash Conversion
Positive cash generation remains a support, but declining free cash flow and operating cash flow below net income indicate weakening earnings conversion. Persistent deterioration could reduce internally funded investment capacity and leave less cash available for expansion, debt management, or shareholder returns.
Low Return On Equity
A very low return on equity suggests Swedencare is currently generating limited profit from the capital invested in the business. Unless returns improve, the sizeable equity base may not translate into attractive earnings power, potentially limiting the efficiency and durability of future growth.
SWDCF FAQ
What was Swedencare AB’s price range in the past 12 months?
What is Swedencare AB’s market cap?
When is Swedencare AB’s upcoming earnings report date?
How were Swedencare AB’s earnings last quarter?
Is Swedencare AB overvalued?
Does Swedencare AB pay dividends?
What is Swedencare AB’s EPS estimate?
How many shares outstanding does Swedencare AB have?
What happened to Swedencare AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Swedencare AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Swedencare AB
Swedencare AB (publ), an enterprise established in 1993 and headquartered in Malmö, Sweden, operates with its subsidiaries to develop, produce, market, and sell a wide array of healthcare products, predominantly for animals. The company's flagship offering is the ProDen PlaqueOff line, focused on dental hygiene for dogs and cats. This popular range includes a food supplement powder designed to reduce plaque and tartar buildup, along with various chewable formats such as dental bites, bones (including mini versions for smaller dogs), and soft chews suitable for both felines and canines. Beyond dental care, Swedencare provides an extensive selection of nutritional supplements under the NutriScience brand for cats, dogs, and horses. These products address diverse health requirements: Glucosamine and Stomax aid in the rejuvenation of joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid supports joint function and mobility; KalmAid offers a calming effect for anxious dogs; while OmegaAid and RevitalAid are formulated to promote healthy skin and coats. Furthermore, the company manufactures specialized supplements for horses, including Gastrocare to alleviate gastric pain and enhance appetite; Equine Gold for overall vitality; a horse-specific ArthriAid to assist with cartilage formation; and AnxiKalm, aimed at soothing excitable horses. Interestingly, Swedencare also caters to human health with ProDen PlaqueOff Teeth and Gums, a natural dietary supplement designed to boost oral hygiene and prevent tartar accumulation. The company's products are distributed through a broad network that includes pharmacies, veterinary clinics, pet stores, animal hospitals, and online channels.
- Sector
- Consumerdefensive
- Industry
- Medical - Pharmaceuticals
- CEO
- Hakan Lagerberg
- Employees
- 589
- Website
- www.swedencare.com
- Address
- Medeon Science Park, Malmö, SN, 205 12, SE
Swedencare AB (SWDCF) Earnings & Revenues
SWDCF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 6 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 7 | 0 | 5 |





